metoclopramide has been researched along with ST Elevated Myocardial Infarction in 2 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stiermaier, T | 1 |
| Schaefer, P | 1 |
| Meyer-Saraei, R | 1 |
| Saad, M | 1 |
| de Waha-Thiele, S | 1 |
| Pöss, J | 1 |
| Fuernau, G | 1 |
| Graf, T | 1 |
| Kurz, T | 1 |
| Frydrychowicz, A | 1 |
| Barkhausen, J | 1 |
| Desch, S | 1 |
| Thiele, H | 1 |
| Eitel, I | 1 |
| Flierl, U | 1 |
| Zauner, F | 1 |
| Sieweke, JT | 1 |
| Berliner, C | 1 |
| Napp, LC | 1 |
| Tillmanns, J | 1 |
| Bauersachs, J | 1 |
| Schäfer, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Morphine Treatment on Platelet Inhibition in Acute Myocardial Infarction[NCT02627950] | Phase 4 | 138 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for metoclopramide and ST Elevated Myocardial Infarction
| Article | Year |
|---|---|
Impact of Morphine Treatment With and Without Metoclopramide Coadministration on Myocardial and Microvascular Injury in Acute Myocardial Infarction: Insights From the Randomized MonAMI Trial.
Topics: Aged; Analgesics, Opioid; Coronary Angiography; Coronary Circulation; Dopamine D2 Receptor Antagonis | 2021 |
Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
Topics: Administration, Oral; Aged; Analgesics, Opioid; Blood Platelets; Dopamine D2 Receptor Antagonists; D | 2017 |